RUM Group Inc. Class A Common Stock vs GeneDx Holdings Corp — how do they compare? RUM Group Inc. Class A Common Stock trades at $6.02 (market cap $2.68B), while GeneDx Holdings Corp trades at $68.8 (market cap $1.94B). The key difference: RUM Group Inc. Class A Common Stock is the larger of the two by market cap, and GeneDx Holdings Corp is more actively traded (524,385 versus 3,201,203). Which is the better fit depends on your goals — on Pluang, investors hold RUM Group Inc. Class A Common Stock for 0 Days and GeneDx Holdings Corp for 20 Days on average.
| RUM | WGS | |
|---|---|---|
Market Cap | $2.68B | $1.94B |
Volume | 3,201,203 | 524,385 |
Sector | Media | Health |
52-Week High | $10.23 | $167.51 |
52-Week Low | $4.67 | $34.51 |
Typical Hold Time | 0 Days | 20 Days |
Enterprise Value | $2.98B | $1.97B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GeneDx (WGS) trades at $64.96, up 1.79% today, showing mixed signals with bearish technical indicators but strong analyst support. The company reported Q2 2026 revenue of $114.4 million, beating expectations with record testing volumes, though profitability remains challenged with negative net margins. Recent news highlights product innovations and leadership recognition, while institutional interest grows with Dimensional Fund Advisors increasing its position by 143.4% in Q1 2026.
The stock presents a high-risk opportunity with 91% analyst buy ratings and an $81 consensus target offering 25% upside. However, significant fundamental challenges include negative profitability, high valuation multiples, and cash flow volatility. Investors should weigh strong growth potential in genomic testing against execution risks and competitive pressures in the healthcare technology sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
RUM Group Inc., formerly Rumble Inc., is a holding company operating two business units: Rumble, an online video-sharing platform, and Quake AI, a cloud computing and artificial-intelligence infrastructure business.
Read more on RUM →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →